×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
4056 views

Au programme de cette soirée

18:00 Introduction
Pr François-Clément Bidard
 
18:05 Thérapeutiques ciblées et immunothérapie
Dr Caroline Bailleux
 
18:25 Chimiothérapie et ADC
Dr Barbara Pistilli
 
18:45 Stratégies thérapeutiques optimales, en général et principaux cas particuliers
Pr François-Clément Bidard
 
19:05 Débat/Discussion et réponses aux questions
 

 

Découvrez les autres webinars du réseau FEM-NET

Webinar #1 Webinar #3

 

Shooting date : 2024-03-19
Last update : 2024-04-03

Suggestions

Thursday, December 2nd 2021 from 06pm to 07pm (GMT+1)
Honolulu : Thursday, December 2nd 2021 from 07am to 08am (GMT+1)
San Francisco : Thursday, December 2nd 2021 from 09am to 10am (GMT+1)
New York : Thursday, December 2nd 2021 from 12pm to 01pm (GMT+1)
Buenos Aires : Thursday, December 2nd 2021 from 02pm to 03pm (GMT+1)
London / Dublin : Thursday, December 2nd 2021 from 05pm to 06pm (GMT+1)
Paris / Berlin : Thursday, December 2nd 2021 from 06pm to 07pm (GMT+1)
Istanbul : Thursday, December 2nd 2021 from 07pm to 08pm (GMT+1)
Moscou / Dubaï : Thursday, December 2nd 2021 from 09pm to 10pm (GMT+1)
Bangkok : Friday, December 3rd 2021 from 12am to 01am (GMT+1)
Shanghai : Friday, December 3rd 2021 from 01am to 02am (GMT+1)
Tokyo : Friday, December 3rd 2021 from 02am to 03am (GMT+1)
Sydney : Friday, December 3rd 2021 from 03am to 04am (GMT+1)
Wellington : Friday, December 3rd 2021 from 05am to 06am (GMT+1)

SLNB or TAD after NAC in cN1 / ycN0 patients

Share
Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 13th 2022 from 07am to 08am (GMT+2)
San Francisco : Thursday, October 13th 2022 from 10am to 11am (GMT+2)
New York : Thursday, October 13th 2022 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, October 13th 2022 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, October 13th 2022 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 13th 2022 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, October 13th 2022 from 09pm to 10pm (GMT+2)
Bangkok : Friday, October 14th 2022 from 12am to 01am (GMT+2)
Shanghai : Friday, October 14th 2022 from 01am to 02am (GMT+2)
Tokyo : Friday, October 14th 2022 from 02am to 03am (GMT+2)
Sydney : Friday, October 14th 2022 from 04am to 05am (GMT+2)
Wellington : Friday, October 14th 2022 from 06am to 07am (GMT+2)

Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

Les nouveaux traitements, entre choix et complémentarité

Share
Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, May 10th 2023 from 07am to 08:30am (GMT+2)
San Francisco : Wednesday, May 10th 2023 from 10am to 11:30am (GMT+2)
New York : Wednesday, May 10th 2023 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Wednesday, May 10th 2023 from 02pm to 03:30pm (GMT+2)
Reykjavik : Wednesday, May 10th 2023 from 05pm to 06:30pm (GMT+2)
London / Dublin : Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Wednesday, May 10th 2023 from 07pm to 08:30pm (GMT+2)
Istanbul : Wednesday, May 10th 2023 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Wednesday, May 10th 2023 from 09pm to 10:30pm (GMT+2)
Bangkok : Thursday, May 11th 2023 from 12am to 01:30am (GMT+2)
Shanghai : Thursday, May 11th 2023 from 01am to 02:30am (GMT+2)
Tokyo : Thursday, May 11th 2023 from 02am to 03:30am (GMT+2)
Sydney : Thursday, May 11th 2023 from 04am to 05:30am (GMT+2)
Wellington : Thursday, May 11th 2023 from 06am to 07:30am (GMT+2)

Cancer du sein : actualités et essais en cours, vers où allons-nous ?

Share
Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Thursday, May 25th 2023 from 07:30am to 09am (GMT+2)
San Francisco : Thursday, May 25th 2023 from 10:30am to 12pm (GMT+2)
New York : Thursday, May 25th 2023 from 01:30pm to 03pm (GMT+2)
Buenos Aires : Thursday, May 25th 2023 from 02:30pm to 04pm (GMT+2)
Reykjavik : Thursday, May 25th 2023 from 05:30pm to 07pm (GMT+2)
London / Dublin : Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Paris / Berlin : Thursday, May 25th 2023 from 07:30pm to 09pm (GMT+2)
Istanbul : Thursday, May 25th 2023 from 08:30pm to 10pm (GMT+2)
Moscou / Dubaï : Thursday, May 25th 2023 from 09:30pm to 11pm (GMT+2)
Bangkok : Friday, May 26th 2023 from 12:30am to 02am (GMT+2)
Shanghai : Friday, May 26th 2023 from 01:30am to 03am (GMT+2)
Tokyo : Friday, May 26th 2023 from 02:30am to 04am (GMT+2)
Sydney : Friday, May 26th 2023 from 04:30am to 06am (GMT+2)
Wellington : Friday, May 26th 2023 from 06:30am to 08am (GMT+2)

Cancer du sein RH+ : Quelles optimisations thérapeutiques en 2L métastatique ?

Share
Scroll Up